Consistent with these experimental findings, our immunohistochemical evaluations of human patients who died of COVID-19 showed reduced ACE2 protein expression by COVID-19 in patients both with and without Alzheimer’s disease (Figure 3). The gene discussed is ACE2; the disease is COVID-19.